Tuberculosis News and Research

Latest Tuberculosis News and Research

Mount Sinai's Arnhold Institute for Global Health and NYC Health + Hospitals launch CURE-19

The Arnhold Institute for Global Health at the Icahn School of Medicine at Mount Sinai and NYC Health + Hospitals have launched the COVID-19 Unit for Research at Elmhurst (CURE-19).

12 Aug 2020

Specific HIV and tuberculosis medications decrease risk of death in adults with drug-resistant TB

After looking at the health records of over 10,000 patients with both HIV and multidrug resistant Tuberculosis (TB) in over 20 different countries, researchers at the Perelman School of Medicine at the University of Pennsylvania in collaboration with the Centers for Disease Control and Prevention, McGill University, and other institutions around the world, found that implementing antiretroviral therapy (ART) for HIV and newer tuberculosis medications decreased the risk of death for adults with drug-resistant TB.

11 Aug 2020

SARS-CoV-2 droplets travel further and last longer than thought, and even more in humid air

The ongoing COVID-19 pandemic is spread by respiratory aerosols, in which tiny droplets of saliva and mucus containing the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are expelled from the upper respiratory tract. Though quite a few studies have investigated the viral load of such droplets, not much is known about how far these droplets move or how long they linger in the air, even though such information is crucial to determining how infectious they are.

10 Aug 2020

KHN’s ‘What the Health?’: Still waiting for that Trump health plan

President Donald Trump keeps promising to unveil a comprehensive plan to replace the Affordable Care Act, but it keeps not appearing.

6 Aug 2020

COVID-19: BCG vaccine is safe and possibly has a positive effect

The BCG vaccine, a vaccine originally made against tuberculosis, has a general stimulating effect on the immune system and is therefore effective against multiple infectious diseases - possibly also against COVID-19.

6 Aug 2020

New UK supply contract for COVID-19 sample collection kits

EKF Diagnostics Holdings plc, the AIM listed point-of-care business, announces that it has received an initial order worth £3 m from a partner from the private sector to supply PrimeStore MTM, a novel patented sample collection device, to be used in a COVID-19 testing programme for UK staff.

From EKF Diagnostics 5 Aug 2020

Mandatory BCG vaccination correlates with flattening of the curve in COVID-19 spread

Scientists have found that countries with mandatory Bacillus Calmette-Guérin (BCG) vaccination until at least the year 2000 tended to exhibit slower infection and death rates during the first 30 days of the outbreak of COVID-19 in their country.

31 Jul 2020

UOttawa's Faculty of Medicine awards 58 clinical research chairs to top clinician-scientists

The Faculty of Medicine has awarded 58 clinical research chairs to top clinician-scientists in a five-year, $40 million investment to drive clinical research excellence and enhance health and patient care.

30 Jul 2020

Multiple, intertwined cell death systems to prevent the spread of 'intracellular' bacteria

Melbourne researchers have revealed the multiple, intertwined cell death systems that prevent the spread of the 'intracellular' bacterium Salmonella, an important cause of typhoid fever which kills more than 100,000 people annually.

30 Jul 2020

Compounds demonstrate promising activity against tuberculosis

Compounds tested for their potential as antibiotics have demonstrated promising activity against one of the deadliest infectious diseases - tuberculosis (TB).

30 Jul 2020

WHO and NDWG launch framework for evaluation of new tests for TB infection

WHO and the Stop TB Partnership's New Diagnostics Working Group launched today a framework for the evaluation of new tests for tuberculosis infection.

29 Jul 2020

Study: HIV, TB, and malaria deaths could increase in low- and middle-income countries

Low- and middle-income countries could see HIV, tuberculosis (TB), and malaria deaths increase by up to 36 per cent over the next five years because of COVID-19-induced health services disruptions, a study projects.

29 Jul 2020

Researchers unlock new insights that may help inform vaccine design for infectious diseases

Vaccination is the most effective public health measure to prevent infectious diseases. Vaccines can greatly reduce the risk of infection by working with the body's natural defenses to safely develop immunity to disease.

28 Jul 2020

Modulating immunometabolic processes to control lung infection

When drugs to kill microbes are ineffective, host-directed therapy uses the body's own immune system to deal with the infection.

23 Jul 2020

New technology could speed up drug discovery to fight tuberculosis

A new technology that combines high throughput imaging and machine learning could speed discovery of drugs to fight tuberculosis, which for generations has killed more people worldwide than any other disease caused by a single agent - 4,000 people every day.

23 Jul 2020

Scientists want to know more about using UV light to fight COVID-19 spread

High up near the ceiling, in the dining room of his Seattle-area restaurant, Musa Firat recently installed a “killing zone” — a place where swaths of invisible electromagnetic energy penetrate the air, ready to disarm the coronavirus and other dangerous pathogens that drift upward in tiny, airborne particles.

22 Jul 2020

Racially motivated hate crimes increase in the U.S.

Under the Hate Crime Statistic Act, hate crimes are defined as "crimes that manifest evidence of prejudice based on race, gender and gender identity, religion, disability, sexual orientation, or ethnicity."

22 Jul 2020

Coronavirus pandemic could be just the “tip of the iceberg” this winter, warns health charity

With experts stating that 120,000 people could perish from Coronavirus in the closing months of the year, a health charity is warning Britain had better brace itself for another crisis – antibiotic resistant infections.

21 Jul 2020

Perspective: T cell reaction to SARS-CoV-2 virus is a crucial target for research

While early research on the adaptive immune response to COVID-19 primarily looked at antibodies, more information is now emerging on how T cells react to the SARS-CoV-2 virus - addressing a crucial knowledge gap, say Daniel Altmann and Rosemary Boyton in a new Perspective.

17 Jul 2020

Latent tuberculosis infection in European countries closely correlates with COVID-19 infection

In a recent medRxiv preprint research paper, scientists from India analyzed twenty European countries and showed that the prevalence of exposure to Mycobacterium spp. (which includes BCG vaccine) is consistently negatively correlated with coronavirus disease (COVID-19) infections.

15 Jul 2020

Tuberculosis News and Research

Latest Tuberculosis News and Research

Mount Sinai's Arnhold Institute for Global Health and NYC Health + Hospitals launch CURE-19

Specific HIV and tuberculosis medications decrease risk of death in adults with drug-resistant TB

SARS-CoV-2 droplets travel further and last longer than thought, and even more in humid air

KHN’s ‘What the Health?’: Still waiting for that Trump health plan

COVID-19: BCG vaccine is safe and possibly has a positive effect

New UK supply contract for COVID-19 sample collection kits

Mandatory BCG vaccination correlates with flattening of the curve in COVID-19 spread

UOttawa's Faculty of Medicine awards 58 clinical research chairs to top clinician-scientists

Multiple, intertwined cell death systems to prevent the spread of 'intracellular' bacteria

Compounds demonstrate promising activity against tuberculosis

WHO and NDWG launch framework for evaluation of new tests for TB infection

Study: HIV, TB, and malaria deaths could increase in low- and middle-income countries

Researchers unlock new insights that may help inform vaccine design for infectious diseases

Modulating immunometabolic processes to control lung infection

New technology could speed up drug discovery to fight tuberculosis

Scientists want to know more about using UV light to fight COVID-19 spread

Racially motivated hate crimes increase in the U.S.

Coronavirus pandemic could be just the “tip of the iceberg” this winter, warns health charity

Perspective: T cell reaction to SARS-CoV-2 virus is a crucial target for research

Latent tuberculosis infection in European countries closely correlates with COVID-19 infection

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Tuberculosis News and Research

Latest Tuberculosis News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in